Alpha DNA Investment Management’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,306
Closed -$1.92M 116
2024
Q4
$1.92M Sell
14,306
-3,783
-21% -$521K 0.73% 25
2024
Q3
$2.2M Sell
18,089
-2,486
-12% -$294K 0.82% 16
2024
Q2
$2.54M Buy
20,575
+5
+0% +$506 0.99% 11
2024
Q1
$1.86M Sell
20,570
-9,570
-32% -$694K 0.69% 33
2023
Q4
$1.49M Buy
30,140
+13,110
+77% +$608K 0.58% 34
2023
Q3
$741K Sell
17,030
-8,240
-33% -$369K 0.3% 76
2023
Q2
$1.07M Sell
25,270
-25,060
-50% -$832K 0.36% 60
2023
Q1
$1.4M Buy
+50,330
New +$1.09M 0.41% 47
2022
Q2
Sell
-50,430
Closed -$1.38M 152
2022
Q1
$1.38M Sell
50,430
-10,740
-18% -$269K 0.97% 29
2021
Q4
$1.8M Sell
61,170
-21,530
-26% -$592K 1.13% 26
2021
Q3
$1.71M Buy
82,700
+6,020
+8% +$125K 1.17% 9
2021
Q2
$1.53M Buy
76,680
+26,560
+53% +$426K 1.05% 30
2021
Q1
$668K Sell
50,120
-19,440
-28% -$261K 0.77% 46
2020
Q4
$908K Buy
+69,560
New +$931K 0.97% 27

Other funds holding NVDA

Alpha DNA Investment Management's NVDA Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of NVIDIA (NVDA) in Q1 2025, closing a stake of 14,306 shares — an estimated $1.92M sold.

Alpha DNA Investment Management first reported a position in NVDA in Q4 2020 and held it in 14 quarters. The position peaked at $2.54M in Q2 2024. 5,129 funds tracked by Wall St. Rank hold NVDA as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining NVIDIA position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 14,306 NVIDIA shares in Q1 2025, an estimated $1.92M.
  • Alpha DNA Investment Management first reported a position in NVIDIA in Q4 2020 and held it in 14 quarters.
  • Alpha DNA Investment Management's NVIDIA position peaked at $2.54M in Q2 2024.
  • 5,129 funds tracked by Wall St. Rank held NVIDIA as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.